Adjunctive probiotic therapy sustains symptom relief in gastroesophageal reflux disease through gut microbiome-metabolome remodeling.
- 2026-02-17
- RCT
- mSystems 11(2)
- Yingmeng Li
- Qiong Li
- Keyu Quan
- Yong Xie
- Ni Yang
- Teng Ma
- Longjin Zheng
- Wei Zhou
- Yalin Li
- Hao Jin
- Zhihong Sun
- Yongfu Chen
- Lai-Yu Kwok
- Nonghua Lu
- Weifeng Zhu
- Wenjun Liu
- Heping Zhang
- PubMed: 41609355
- DOI: 10.1128/msystems.01568-25
- High evidence
- Rigorous Journal
Compared with the placebo group, the probiotic group exhibited a pronounced 36.51% reduction in RDQ scores after 12 weeks of intervention (P = 0.017), alongside a higher numerical endoscopic healing rate (36.84% vs 12.50%; P = 0.365).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes